GCGR and metabolic dysfunction-associated steatohepatitis: Activation of the glucagon receptor in the peripheral tissues increases energy expenditure, thus promoting a negative energy balance and weight loss; in the liver, it reduces lipid accumulation, oxidative stress, and inflammation while decreasing fibrosis, a hallmark of MASH [71,72,73].